NM_203395.3:c.315_317delCAT
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM2PM4_SupportingPP5
The NM_203395.3(IYD):c.315_317delCAT(p.Phe105_Ile106delinsLeu) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00025 in 1,613,976 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_203395.3 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000103 AC: 26AN: 251400Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135872
GnomAD4 exome AF: 0.000259 AC: 379AN: 1461798Hom.: 0 AF XY: 0.000249 AC XY: 181AN XY: 727204
GnomAD4 genome AF: 0.000158 AC: 24AN: 152178Hom.: 0 Cov.: 32 AF XY: 0.000135 AC XY: 10AN XY: 74338
ClinVar
Submissions by phenotype
Iodotyrosine deiodination defect Pathogenic:2
- -
- -
IYD-related disorder Pathogenic:1
The IYD c.315_317delCAT variant is predicted to result in an in-frame deletion (p.Phe105_Ile106delinsLeu). This variant was reported in two homozygous individuals with goitrous hypothyroidism (Moreno et al. 2008. PubMed ID: 18434651). This variant is reported in 0.022% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/6-150710622-TTCA-T). This variant is interpreted as likely pathogenic. -
not specified Uncertain:1
The c.315_317delCAT (p.F105_I106delinsL) alteration is located in exon 2 (coding exon 2) of the IYD gene. This alteration consists of an in-frame deletion of 3 nucleotides between nucleotide positions c.315 and c.317, resulting in the deletion of 1 residue. The p.F105_I106delinsL alteration is predicted to be deleterious with a score of -10.5 by PROVEAN in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at